After hours: September 20 at 5:05 PM EDT ...

Despite decades of widespread treatment with the antibiotic vancomycin, vancomycin resistance among the bacterium S. aureus is extremely uncommon-;only 16 such cases have reported in the U.S. to date.

Purpose An original and a revised vancomycin dosing protocol for obese patients were compared with respect to attainment of target serum trough vancomycin concentrations and the occurrence of ...

More information: Vancomycin-resistant Staphylococcus aureus (VRSA) can overcome the cost of antibiotic resistance and may threaten vancomycin's clinical durability, PLOS Pathogens (2024). DOI: 10 ...

Purpose. The feasibility of using a limitedsampling algorithm for administration of vancomycin for treatment of vascular-access-related bacteremia in outpatient high flux hemodialysis was ...

A new Lancet study forecast what may happen over the next 25 years if more isn't done to address antimicrobial resistant ...

The cost-effectiveness threshold was $50,000 per quality-adjusted life year (QALY).

The Medical News Today news team reports on emerging science, cutting-edge research, new treatments, and trending topics in health and medicine. All articles are written by our network of editors ...

The small-molecule protein synthesis inhibitor CRS3121 met its primary endpoints, with high rates of clinical cure at day 12 ...